Publications by authors named "Amy Brownlee"

Mixed neuroendocrine-nonneuroendocrine (MiNEN) neoplasms in the head and neck are exceptionally rare biphasic tumors with unclear pathogenesis and an aggressive clinical behavior. This is the first reported case of an oropharyngeal MiNEN with the nonneuroendocrine component being an HPV-associated adenocarcinoma. The tumor arose in a 56 year-old male with history of long-term cigarette smoking and was composed of an adenocarcinoma intermixed with a small cell neuroendocrine carcinoma.

View Article and Find Full Text PDF

The most common subtype of lymphoma globally, diffuse large B cell lymphoma (DLBCL), is a leading cause of cancer death in people with HIV. The restructuring of the T cell compartment because of HIV infection and antiretroviral therapy (ART) may have implications for modern treatment selection, but current understanding of these dynamic interactions is limited. Here, we investigated the T cell response to DLBCL by sequencing the T cell receptor (TCR) repertoire in a cohort of HIV-negative (HIV-), HIV+/ART-experienced, and HIV+/ART-naive patients with DLBCL.

View Article and Find Full Text PDF
Article Synopsis
  • Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma, making up 40% of new non-Hodgkin lymphoma cases and significantly affecting people living with HIV, who have a much higher risk of developing it.
  • The study explores the differences between HIV-positive and HIV-negative DLBCL at a molecular level, revealing that these groups react differently to therapy and have varying clinical outcomes, particularly among those on or off antiretroviral treatment (ART).
  • Findings indicate that HIV+ and ART-naïve patients show more favorable outcomes, while established biomarkers are limited; however, differences in immune responses are linked to tumor interactions, suggesting new therapeutic avenues based on patient status.
View Article and Find Full Text PDF

The pathology laboratory at Kamuzu Central Hospital (KCH) in Lilongwe, Malawi was established in 2011. We published our initial experiences in laboratory development and telepathology in 2013 and 2016, respectively. The purpose of this paper is to provide an update on our work by highlighting the positive role laboratory development has played in improving regional cancer care and research.

View Article and Find Full Text PDF